P Szulc1, J M Kaufman, P D Delmas. 1. INSERM Research Unit 831, University of Lyon, Lyon, France. szulc@lyon.inserm.fr
Abstract
UNLABELLED: Osteoporosis in men is less studied than in women. Few data concern biochemical bone turnover markers (BTM) in men and their potential use. METHODOLOGY: We evaluated papers concerning BTM in men cited on Medline. Selection of studies were based on the number of subjects, age range, group homogeneity, follow-up duration, number of BTM. RESULTS: BTM levels are high in young men, then decrease with age. In elderly men, bone resorption increases with age more than bone formation. Variability of individual values is high and their significance is unclear. In elderly men, BTM levels correlate negatively with bone mineral density suggesting that accelerated bone turnover underlies age-related bone loss. Data on the prediction of accelerated bone loss and fractures by BTM in men are scant. Testosterone treatment induces a decrease in bone resorption followed by a decrease in bone formation. Bisphosphonates and calcitonin decrease BTM levels in osteoporotic men. Parathyroid hormone 1-34 and growth hormone induce a rapid increase in bone turnover followed by a progressive slowdown. CONCLUSIONS: Few studies concern BTM in men. Currently available data are not sufficient to suggest guidelines for the practical use of BTM in the clinical management of the osteoporosis in elderly men.
UNLABELLED: Osteoporosis in men is less studied than in women. Few data concern biochemical bone turnover markers (BTM) in men and their potential use. METHODOLOGY: We evaluated papers concerning BTM in men cited on Medline. Selection of studies were based on the number of subjects, age range, group homogeneity, follow-up duration, number of BTM. RESULTS:BTM levels are high in young men, then decrease with age. In elderly men, bone resorption increases with age more than bone formation. Variability of individual values is high and their significance is unclear. In elderly men, BTM levels correlate negatively with bone mineral density suggesting that accelerated bone turnover underlies age-related bone loss. Data on the prediction of accelerated bone loss and fractures by BTM in men are scant. Testosterone treatment induces a decrease in bone resorption followed by a decrease in bone formation. Bisphosphonates and calcitonin decrease BTM levels in osteoporoticmen. Parathyroid hormone 1-34 and growth hormone induce a rapid increase in bone turnover followed by a progressive slowdown. CONCLUSIONS: Few studies concern BTM in men. Currently available data are not sufficient to suggest guidelines for the practical use of BTM in the clinical management of the osteoporosis in elderly men.
Authors: P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; J H Holmes; A Dlewati; J Staley; J Santanna; S C Kapoor; M F Attie; J G Haddad; B L Strom Journal: J Clin Endocrinol Metab Date: 1999-06 Impact factor: 5.958
Authors: Christina Wang; Glenn Cunningham; Adrian Dobs; Ali Iranmanesh; Alvin M Matsumoto; Peter J Snyder; Thomas Weber; Nancy Berman; Laura Hull; Ronald S Swerdloff Journal: J Clin Endocrinol Metab Date: 2004-05 Impact factor: 5.958
Authors: H Tobiume; S Kanzaki; S Hida; T Ono; T Moriwake; S Yamauchi; H Tanaka; Y Seino Journal: J Clin Endocrinol Metab Date: 1997-07 Impact factor: 5.958
Authors: Colleen Christmas; Kieran G O'Connor; S Mitchell Harman; Jordan D Tobin; Thomas Münzer; Michele F Bellantoni; Carol St Clair; Katharine M Pabst; John D Sorkin; Marc R Blackman Journal: J Gerontol A Biol Sci Med Sci Date: 2002-01 Impact factor: 6.053
Authors: K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis Journal: N Engl J Med Date: 1998-07-30 Impact factor: 91.245
Authors: W F Lems; M C Lodder; P Lips; J W J Bijlsma; P Geusens; N Schrameijer; C M van de Ven; B A C Dijkmans Journal: Osteoporos Int Date: 2006-02-03 Impact factor: 4.507
Authors: S Scholtissen; F Guillemin; O Bruyère; J Collette; B Dousset; C Kemmer; S Culot; D Crémer; H Dejardin; G Hubermont; D Lefebvre; V Pascal-Vigneron; G Weryha; J Y Reginster Journal: Osteoporos Int Date: 2008-11-15 Impact factor: 4.507
Authors: V Breuil; E Fontas; R Chapurlat; P Panaia-Ferrari; H B Yahia; S Faure; L Euller-Ziegler; E Z Amri; P Szulc Journal: Osteoporos Int Date: 2015-06-25 Impact factor: 4.507
Authors: B B Yeap; S A P Chubb; L Flicker; K A McCaul; P R Ebeling; G J Hankey; J P Beilby; P E Norman Journal: Osteoporos Int Date: 2011-02-26 Impact factor: 4.507
Authors: Douglas C Bauer; Patrick Garnero; Stephanie L Harrison; Jane A Cauley; Richard Eastell; Kris E Ensrud; Eric Orwoll Journal: J Bone Miner Res Date: 2009-12 Impact factor: 6.741
Authors: Dirk Vanderschueren; Michaël R Laurent; Frank Claessens; Evelien Gielen; Marie K Lagerquist; Liesbeth Vandenput; Anna E Börjesson; Claes Ohlsson Journal: Endocr Rev Date: 2014-09-09 Impact factor: 19.871